{
  "alleleExist":false,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"PALB2 is a component of the Fanconi anemia complementation (FANCC) group involved in DNA double-strand break repair. Germline mutations of PALB2 are associated with Fanconi anemia and predispose to breast cancer.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"08/08/2018",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[]
    },
    "description":"",
    "knownEffect":"Unknown"
  },
  "oncogenic":"Unknown",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"F588V",
    "alterationType":null,
    "consequence":"missense_variant",
    "entrezGeneId":79728,
    "hgvs":"16:g.23630392A>C",
    "hugoSymbol":"PALB2",
    "id":null,
    "proteinEnd":588,
    "proteinStart":588,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":false,
  "variantSummary":"The biologic significance of the PALB2 F588V mutation is unknown.",
  "vus":false
}